Schroder Investment Management Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Buy |
406,425
+382,425
| +1,593% | +$3.59M | ﹤0.01% | 819 |
|
|
2025
Q1 | $194K | Hold |
24,000
| – | – | ﹤0.01% | 1163 |
|
|
2024
Q4 | $274K | Sell |
24,000
-61,999
| -72% | -$707K | ﹤0.01% | 1152 |
|
|
2024
Q3 | $1.81M | Sell |
85,999
-485
| -0.6% | -$10.2K | ﹤0.01% | 953 |
|
|
2024
Q2 | $1.94M | Sell |
86,484
-441
| -0.5% | -$9.87K | ﹤0.01% | 934 |
|
|
2024
Q1 | $2.39M | Sell |
86,925
-1,577
| -2% | -$43.4K | ﹤0.01% | 897 |
|
|
2023
Q4 | $2.7M | Sell |
88,502
-41,197
| -32% | -$1.26M | ﹤0.01% | 866 |
|
|
2023
Q3 | $4.1M | Sell |
129,699
-12,473
| -9% | -$394K | 0.01% | 787 |
|
|
2023
Q2 | $5.8M | Sell |
142,172
-22,131
| -13% | -$903K | 0.01% | 758 |
|
|
2023
Q1 | $6.12M | Buy |
164,303
+56,689
| +53% | +$2.11M | 0.01% | 738 |
|
|
2022
Q4 | $3.75M | Buy |
107,614
+23,754
| +28% | +$829K | 0.01% | 829 |
|
|
2022
Q3 | $4.69M | Sell |
83,860
-7,631
| -8% | -$427K | 0.01% | 784 |
|
|
2022
Q2 | $4.8M | Buy |
91,491
+1,744
| +2% | +$91.4K | 0.01% | 795 |
|
|
2022
Q1 | $6.48M | Buy |
+89,747
| New | +$6.48M | 0.01% | 776 |
|